|
|||||
|
|
Clinical Implications of the Progression‐Free Survival Endpoint for Treatment of Hormone Receptor‐Positive Advanced Breast Cancer |
|
| Authors: | Virginia G. Kaklamani |
| Affiliation: | Division of Hematology/Oncology, Breast Cancer Program, Cancer Therapy & Research Center, School of Medicine, University of Texas, San Antonio, Texas, USA |
| Abstract: | |
| Keywords: | Breast cancer Progression‐free survival mTOR serine‐threonine kinases Cyclin‐dependent kinases |